Delivering RNA therapies.
Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.
What they do:
Unleash the potential of genomic medicine using AI
Quick facts:
Funding:
€23.2M · Series B · Oct 2026
What they do:
Enabling T cell immunotherapy discovery, development and manufacturing
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
Quick facts:
HQ: New York, NY, United States
What they do:
Developing milk-inspired therapeutics for infectious diseases
Quick facts:
HQ: Davis, CA, United States
What they do:
Deliver genes to any cell with AI
Quick facts:
HQ: London, United Kingdom
What they do:
Cell-specific genetic medicines
Quick facts:
HQ: London, United Kingdom
Delivering RNA therapies.
London, United Kingdom
27 employees, according to the company profile.
There are no funding rounds for Sixfold Bioscience in our data.
Similar startups: WhiteLab Genomics, Indee Labs, and Gilgamesh Pharmaceuticals.